Ryan Zimmerman

BTIG | Healthcare

Ryan Zimmerman is an analyst from BTIG specializing in the Healthcare sector. Ranked #1629 out of 4672 analysts, they have issued 92 stock ratings with a success rate of 90.65% and an average return of 7.22%.

Ryan Zimmerman has a well-established track record, with 92 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 90.65% and an average return of 7.22%, underscoring their expertise and ability to identify winning opportunities for investors.

#1629

Out of 4672

92

Total Ratings

+90.65%

Success Rate

+7.22%

Average Return

Recent Ratings Analysis

MDT

Jun 04, 2026

Target

$90.00

Current

$77.95

Performance

—

Ryan Zimmerman rated MDT as Buy on Jun 04, 2026, setting a price target of 90. Shares have remained stable near 77.95, leaving the 90 target still in play.

MOBI

Jun 02, 2026

Target

$19.00

Current

$13.73

Performance

—

On Jun 02, 2026, MOBI was given a Buy rating by Ryan Zimmerman, with a target price of 19. The stock traded sideways with a % move, keeping the bullish thesis unresolved.

MDAI

May 27, 2026

Target

$4.00

Current

$1.94

Performance

-16.02%

MDAI received a Buy rating from Ryan Zimmerman on May 27, 2026, aiming for 4. The rating hasn’t played out as hoped, with the stock trading 16.02% below expectations.

ENOV

May 22, 2026

Target

$39.00

Current

$21.56

Performance

-10.87%

On May 22, 2026, Ryan Zimmerman published a Buy outlook on ENOV, with a target of 39. Market action contradicted the Buy thesis, as shares slipped to 21.56.

GKOS

May 21, 2026

Target

$162.00

Current

$113.64

Performance

-18.26%

Ryan Zimmerman on May 21, 2026 assigned GKOS a Buy rating, with a price target of 162. The call has struggled to gain traction, with shares losing 18.26%.

TCMD

May 21, 2026

Target

$40.00

Current

$24.37

Performance

-4.92%

On May 21, 2026, Ryan Zimmerman reaffirmed TCMD with a Buy rating, targeting 40. Market indecision has kept the 40 target in a holding pattern.

XTNT

May 13, 2026

Target

$1.00

Current

$0.46

Performance

-4.15%

XTNT was rated Buy by Ryan Zimmerman on May 13, 2026, with a price objective of 1. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

HUMA

May 13, 2026

Target

$2.00

Current

$1.40

Performance

23.89%

On May 13, 2026, Ryan Zimmerman initiated coverage on HUMA with a Buy rating and target of 2. The stock’s climb of 23.89% since the call highlights the foresight in the rating.

SOLV

May 06, 2026

Target

$89.00

Current

$78.36

Performance

10.37%

Ryan Zimmerman issued a Buy recommendation for SOLV on May 06, 2026, price target set at 89. Investors following the Buy call captured upside momentum, with shares now at 78.36.

ALC

May 06, 2026

Target

$82.00

Current

$64.22

Performance

-1.82%

On May 06, 2026, ALC was evaluated by Ryan Zimmerman, who gave a Buy rating and target of 82. So far, the Buy call awaits clearer momentum, with shares flat at 64.22.

CARL

May 06, 2026

Target

$23.00

Current

$10.20

Performance

3.66%

Ryan Zimmerman rated CARL as Buy on May 06, 2026, setting a price target of 23. Shares have remained stable near 10.2, leaving the 23 target still in play.

SYK

May 01, 2026

Target

$379.00

Current

$295.00

Performance

—

On May 01, 2026, SYK was given a Buy rating by Ryan Zimmerman, with a target price of 379. The stock traded sideways with a % move, keeping the bullish thesis unresolved.

KIDS

May 01, 2026

Target

$24.00

Current

$16.92

Performance

—

KIDS received a Buy rating from Ryan Zimmerman on May 01, 2026, aiming for 24. Price action was muted, as shares hovered around 16.92 despite the bullish outlook.

GEHC

Apr 29, 2026

Target

$80.00

Current

$62.03

Performance

4.27%

On Apr 29, 2026, Ryan Zimmerman published a Buy outlook on GEHC, with a target of 80. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 62.03.

ISRG

Apr 22, 2026

Target

$574.00

Current

$407.29

Performance

-15.78%

Ryan Zimmerman on Apr 22, 2026 assigned ISRG a Buy rating, with a price target of 574. The call has struggled to gain traction, with shares losing 15.78%.

ORGO

Mar 26, 2026

Target

$8.00

Current

$2.33

Performance

—

On Mar 26, 2026, Ryan Zimmerman reaffirmed ORGO with a Buy rating, targeting 8. Market indecision has kept the 8 target in a holding pattern.

LNSR

Mar 18, 2026

Target

$10.00

Current

$5.74

Performance

-12.77%

LNSR was rated Buy by Ryan Zimmerman on Mar 18, 2026, with a price objective of 10. This case shows how bullish projections can fail, with the stock now below 5.74.

SI

Mar 11, 2026

Target

$24.00

Current

$13.83

Performance

-1.28%

On Mar 11, 2026, Ryan Zimmerman initiated coverage on SI with a Buy rating and target of 24. Neutral price movement of -1.28% leaves room for interpretation.

ZBH

Feb 10, 2026

Target

$112.00

Current

$84.98

Performance

-7.02%

Ryan Zimmerman issued a Buy recommendation for ZBH on Feb 10, 2026, price target set at 112. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

PEN

Jan 16, 2026

Target

$349.00

Current

$319.37

Performance

-8.95%

On Jan 16, 2026, PEN was evaluated by Ryan Zimmerman, who gave a Neutral rating and target of 349. The Hold call avoided chasing into subsequent weakness of 8.95%.

RBOT

Dec 12, 2025

Target

—

Current

$0.61

Performance

-76.17%

Ryan Zimmerman rated RBOT as Neutral on Dec 12, 2025, setting a price target of null. The cautious Hold call aligned with subsequent weakness, as shares slipped 76.17%.

RCEL

Nov 20, 2025

Target

—

Current

$4.16

Performance

8.33%

On Nov 20, 2025, RCEL was given a Neutral rating by Ryan Zimmerman, with a target price of null. The stock rallied from 4.16 to 4.16 after the Hold rating, surprising to the upside.

TMCI

Nov 07, 2025

Target

—

Current

$3.40

Performance

-23.94%

TMCI received a Neutral rating from Ryan Zimmerman on Nov 07, 2025, aiming for null. The Hold stance proved prudent, with the market softening by 23.94%.

HOLX

Oct 21, 2025

Target

—

Current

$76.01

Performance

2.74%

On Oct 21, 2025, Ryan Zimmerman published a Neutral outlook on HOLX, with a target of null. Sideways action left the Hold view intact, with no major move since 76.01.

IRTC

Oct 13, 2025

Target

$195.00

Current

$104.56

Performance

-41.05%

Ryan Zimmerman on Oct 13, 2025 assigned IRTC a Buy rating, with a price target of 195. The call has struggled to gain traction, with shares losing 41.05%.

VCEL

Sep 17, 2025

Target

—

Current

$34.74

Performance

15.72%

On Sep 17, 2025, Ryan Zimmerman reaffirmed VCEL with a Neutral rating, targeting null. Market strength beyond 34.74 went further than the conservative outlook suggested.

PRCT

Sep 16, 2025

Target

—

Current

$26.33

Performance

-33.46%

PRCT was rated Neutral by Ryan Zimmerman on Sep 16, 2025, with a price objective of null. Investors who stayed cautious avoided some of the 33.46% decline.

RXST

Jul 09, 2025

Target

—

Current

$4.79

Performance

-39.75%

On Jul 09, 2025, Ryan Zimmerman initiated coverage on RXST with a Neutral rating and target of null. The rating matched the stock’s inability to hold above 4.79.

GMED

Dec 12, 2024

Target

$91.00

Current

$77.95

Performance

-5.76%

Ryan Zimmerman issued a Buy recommendation for GMED on Dec 12, 2024, price target set at 91. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

IART

Oct 07, 2024

Target

—

Current

$16.10

Performance

-7.63%

On Oct 07, 2024, IART was evaluated by Ryan Zimmerman, who gave a Neutral rating and target of null. The Hold call avoided chasing into subsequent weakness of 7.63%.

STAA

Jul 15, 2024

Target

$53.00

Current

$28.26

Performance

-37.51%

Ryan Zimmerman rated STAA as Buy on Jul 15, 2024, setting a price target of 53. The stock has underperformed, dropping 37.51% despite the bullish target of 53.

Frequency Asked Questions

Who is Ryan Zimmerman?

Ryan Zimmerman is an analyst from BTIG specializing in the Healthcare sector.

What is Ryan Zimmerman's success rate?

Ryan Zimmerman currently has a success rate of +90.65%.

How many ratings has Ryan Zimmerman issued?

Ryan Zimmerman has issued 92 stock ratings so far.

What is the average return of Ryan Zimmerman's calls?

Their stock ratings have generated an average return of +7.22%.

What is Ryan Zimmerman's ranking?

Ryan Zimmerman is ranked #1629 out of 4672 analysts.

What types of ratings does Ryan Zimmerman give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Ryan Zimmerman?

You can follow Ryan Zimmerman by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Ryan Zimmerman?

Their latest rating was a Buy on MDT issued on 2026-06-04.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep